Regulatory

Latest News

child in need of psoraisis biosimilar | Image credit: WESTOCK - stock.adobe.com
FDA Approves Steqeyma for Children With Plaque Psoriasis, Psoriatic Arthritis

June 17th 2025

Celltrion's FDA approval of Steqeyma enhances pediatric psoriasis treatment, offering flexible dosing options for children with chronic inflammatory conditions.

biosimilar regulatory roundup banner
Biosimilars Regulatory Roundup: May 2025

May 31st 2025

Eye on Pharma banner
Eye on Pharma: Interchangeability Labels and Expanded Biosimilar Partnerships

May 29th 2025

FDA has approved 8 ustekinumab biosimilars in total. | Image Credit: wladimir1804 - stock.adobe.com
FDA Approves Starjemza as New Stelara Biosimilar

May 27th 2025

doctor talking to patients about anti-tnf therapy for IBD | Image credit: sebra - stock.adobe.com
Biosimilars Can Help Expand Early Access Anti-TNF Therapy in IBD

May 26th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.